DAVITA HEALTHCARE PARTNERS INC. 4
4 · DAVITA HEALTHCARE PARTNERS INC. · Filed Jul 13, 2016
Insider Transaction Report
Form 4
JIGANTI JEANINE MARIE
Chief Compliance Officer
Transactions
- Sale
Common Stock
2016-07-11$78.51/sh−938$73,645→ 3,840 total - Sale
Common Stock
2016-07-11$78.51/sh−353$27,715→ 4,478 total - Exercise/Conversion
Common Stock
2016-07-11$48.68/sh+938$45,662→ 5,716 total - Tax Payment
Common Stock
2016-07-11$78.07/sh−585$45,671→ 5,131 total - Exercise/Conversion
Stock Appreciation Rights
2016-07-11−938→ 0 totalExercise: $48.68From: 2013-07-09Exp: 2017-07-09→ Common Stock (938 underlying)
Footnotes (4)
- [F1]The exercise and sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2016.
- [F2]Represents the weighted average sale price of $78.5118. The range of prices for the sale of these shares was $78.49 - $78.53, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average sale price of $78.5131. The range of prices for the sale of these shares was $78.49 - $78.52, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]The Stock Appreciation Rights were granted on 7/9/2012. 25% vested on 7/9/2013, then 6.25% vested every three months thereafter.